Objective: To determine whether non-HDL cholesterol, a measure of total cholesterol minus HDL cholesterol, is a predictor of CVD in patients with diabetes. Research Design and Methods: The Strong ...

Pharma companies Merck & Co. Inc. and Glenmark Pharmaceuticals Ltd. convinced a judge to throw out several claims alleging they illegally monopolized the market for popular cholesterol-lowering drugs ...

but who have high cholesterol and are on statins, which lower LDL by increasing LDLR in cells. By knowing precisely where and how LDLR binds to LDL, the researchers say they may now be able to target ...

Without robust evidence of benefits of primary prevention statin use in women with elevated cholesterol, and some evidence of cardiac risk for some statins or subgroups of women, the cardiology ...

A recent groundbreaking study published in the journal NEJM Evidence found no association between exposure to very low cholesterol levels achieved with PCSK9 inhibition and statin therapy and ...

My yearly wellness test was excellent, except my cholesterol and LDL levels were ... Many experts believe that statin drugs aren’t quite as effective in people above 75; however, because age ...

The prescription drug file was used to identify medication exposure based on the generic and brand names ... Kaplan–Meier survival curves between two groups indicated the 30-day mortality risk for the ...

My yearly wellness test was excellent, except my cholesterol and LDL levels were 250 mg/dL and 150 mg/dL, respectively. What is the risk/benefit level of statins for me? {span}—{/span} ...

But ironically the oral version, when used as a blood pressure medication ... for statin-intolerant patients, he believes statins will remain the first-line treatment for high cholesterol.

But ironically the oral version, when used as a blood pressure medication ... Specialists and patients are hopeful a new non-statin, cholesterol-lowering drug will go to the Therapeutic Goods ...